Wiegand MA - Search Results

1

De novo synthesis of N and P proteins as a key step in Sendai virus gene expression.

Wiegand MA, Bossow S, Schlecht S, Neubert WJ. Wiegand MA, et al. J Virol. 2007 Dec;81(24):13835-44. doi: 10.1128/JVI.00914-07. Epub 2007 Sep 12. J Virol. 2007. PMID: 17855540 Free PMC article.

2

Sendai virus trailer RNA simultaneously blocks two apoptosis-inducing mechanisms in a cell type-dependent manner.

Wiegand M, Bossow S, Neubert WJ. Wiegand M, et al. J Gen Virol. 2005 Aug;86(Pt 8):2305-2314. doi: 10.1099/vir.0.81022-0. J Gen Virol. 2005. PMID: 16033978

3

Evaluation of nucleocapsid and phosphoprotein p functionality as critical factors during the early phase of paramyxoviral infection.

Bossow S, Schlecht S, Schubbert R, Pfeiffer M, Neubert WJ, Wiegand M. Bossow S, et al. Open Virol J. 2012;6:73-81. doi: 10.2174/1874357901206010073. Epub 2012 Jun 14. Open Virol J. 2012. PMID: 22787520 Free PMC article.

4

Evaluation of a novel immunogenic vaccine platform based on a genome replication-deficient Sendai vector.

Wiegand M, Gori-Savellini G, Martorelli B, Bossow S, Neubert WJ, Cusi MG. Wiegand M, et al. Vaccine. 2013 Aug 20;31(37):3888-93. doi: 10.1016/j.vaccine.2013.06.053. Epub 2013 Jul 2. Vaccine. 2013. PMID: 23831325

5

Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors.

Kiener R, Fleischmann M, Wiegand MA, Lemmermann NAW, Schwegler C, Kaufmann C, Renzaho A, Thomas S, Felder E, Niller HH, Asbach B, Wagner R. Kiener R, et al. Among authors: wiegand ma. J Virol. 2018 Jul 17;92(15):e00569-18. doi: 10.1128/JVI.00569-18. Print 2018 Aug 1. J Virol. 2018. PMID: 29769344 Free PMC article.

6

A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease.

Wiegand MA, Gori-Savellini G, Gandolfo C, Papa G, Kaufmann C, Felder E, Ginori A, Disanto MG, Spina D, Cusi MG. Wiegand MA, et al. J Virol. 2017 Apr 28;91(10):e02298-16. doi: 10.1128/JVI.02298-16. Print 2017 May 15. J Virol. 2017. PMID: 28250126 Free PMC article.

7

Quantitative proteomics reveals subset-specific viral recognition in dendritic cells.

Luber CA, Cox J, Lauterbach H, Fancke B, Selbach M, Tschopp J, Akira S, Wiegand M, Hochrein H, O'Keeffe M, Mann M. Luber CA, et al. Immunity. 2010 Feb 26;32(2):279-89. doi: 10.1016/j.immuni.2010.01.013. Epub 2010 Feb 18. Immunity. 2010. PMID: 20171123 Free article.

8

Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses.

Liniger M, Zuniga A, Morin TN, Combardiere B, Marty R, Wiegand M, Ilter O, Knuchel M, Naim HY. Liniger M, et al. Vaccine. 2009 May 26;27(25-26):3299-305. doi: 10.1016/j.vaccine.2009.01.057. Epub 2009 Feb 5. Vaccine. 2009. PMID: 19200842 Free PMC article.

9

Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses.

Liniger M, Zuniga A, Tamin A, Azzouz-Morin TN, Knuchel M, Marty RR, Wiegand M, Weibel S, Kelvin D, Rota PA, Naim HY. Liniger M, et al. Vaccine. 2008 Apr 16;26(17):2164-74. doi: 10.1016/j.vaccine.2008.01.057. Epub 2008 Feb 22. Vaccine. 2008. PMID: 18346823 Free PMC article.

10

Sequence and immunogenicity of a clinically approved novel measles virus vaccine vector.

Zuniga A, Liniger M, Morin TN, Marty RR, Wiegand M, Ilter O, Weibel S, Billeter MA, Knuchel MC, Naim HY. Zuniga A, et al. Among authors: wiegand m. Hum Vaccin Immunother. 2013 Mar;9(3):607-13. doi: 10.4161/hv.23242. Epub 2013 Jan 16. Hum Vaccin Immunother. 2013. PMID: 23324616 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters